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P1-105 
Inactivation of the novel avian influenza virus A (H7N9) under physical 
conditions or chemical agents treatment 
S Zou*, J Guo, R Gao, L Dong, J Zhou, Y Zhang, J Dong, Y Shu 
National Influenza Center, National Institute for Viral Disease Control and Prevention, China Center 
for Disease Control and Prevention, Beijing, China 
Background: During the spring of 2013, the emergence and spread of a novel avian-origin influenza A 
(H7N9) virus in humans in eastern China has raised concerns that a new influenza pandemic could 
occur. The potential effect of chemical agents and physical conditions on inactivation of the novel 
H7N9 virus has not been assessed. Materials and Methods: To determine the survival of the H7N9 
isolates under various physical and chemical treatments, two H7N9 isolates, A/Anhui/1/2013 and 
A/Shanghai/1/2013, were treated by varied temperatures, ultraviolet light, varied pHs and 
disinfectants. The viruses with a concentration of 107.7 EID50 were exposed to physical (temperature, 
ultraviolet light and pH) and commercial chemical (chlorine, Virkon S, and ethanol) agents. Harvested 
allantoic fluid from embryonated SPF chicken eggs inoculated with H7N9 treated virus was subjected 
to haemagglutination assay. Results: Both the tested viruses can tolerate 15-min exposure to 56°C 
but lost their infectivity totally when exposed to the temperature of 56°C for 30 min, and also readily 
inactivated by 65°C for at least 10 min, 70°C for 5 min or 100°C for 1 min. It was also observed the 
H7N9 viruses lost their viability after they were exposed to ultraviolet light radiation for 30 minutes or 
longer. Additionally, acidic pH 1-3 was virucidal after 0.5 h (pH1-2) or overnight (pH3) contact time. 
But, the virus retained infectivity after contacting pH 4-12 for 24 h. In addition, the virus would lose 
infectivity when exposed to chlorine, Virkon S and ethanol at recommended concentrations after only 
5-10 min. Conclusions: The novel virus can be inactivated by general physical or chemical treatments, 
but presents a high tolerance on acidic or alkali conditions. The results provide support for public 
awareness of protection against the novel virus or the decontamination method of the novel virus at 
laboratory and field conditions. 
P1-106 
Pathogenesis of the novel avian-origin influenza A (H7N9) virus in human 
lower respiratory tract 
LLY Chan1*, RWY Chan1, JSM Peiris1, MCW Chan1 
1Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, University of 
Hong Kong, Pokfulam, Hong Kong SAR, China 
Background: As of May 2013, 131 laboratory-confirmed human infections with a novel influenza H7N9 
virus had been reported from China. The source of human infection appears to be poultry. There is so 
far no evidence of sustained human-to-human transmission. Genetic analysis revealed that all eight 
gene segments of H7N9 were of avian origin; six internal gene segments from avian influenza H7N9 
viruses, while hemagglutinin and neuraminidase genes were derived from influenza viruses circulating 
in ducks and wild ducks, respectively. The emergence of the H7N9 influenza virus catches global 
attention about whether the new virus could spark another pandemic. The majority of the infected 
patients were hospitalized and suffered from ARDS, with a fatality rate of about 37%. Our study aimed 
to determine the mechanism contributing to the pathogenesis of the H7N9 virus. A panel of 
proinflammatory cytokines and chemokines will be examined upon influenza H7N9 virus infection in 
alveolar epithelial cells in order to examine if these mediators were induced differentially when 
compared with the highly pathogenic avian influenza (HPAI) H5N1 and the 2009 pandemic H1N1 
virus. Moreover, because cleaved caspase 3 is commonly employed as a marker for the indication of 
apoptosis, we further examined the extensiveness of cleaved caspase 3 in influenza virus infection in 
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human lung ex vivo cultures. Materials and Methods: Fresh biopsies of human lung tissue were 
obtained from patients undergoing surgical resection of lung tissues. Lung tissue fragments were 
cultured with F12K medium incubated at 37°C. For viral infection experiments, influenza viruses 
A/Shanghai/1/2013 (SH1, H7N9), A/Shanghai/2/2013 (SH2, H7N9), A/Hong Kong/483/97 (H5N1), 
and A/California/07 (Ca07, H1N1pdm) at a viral titer of 106 TCID50/mL were used for ex vivo lung 
culture infection. Infected lung tissues were collected in 10% formalin at 24, 48, and 72 hpi for 
immunohistochemical staining. Costaining of cleaved caspase 3 and influenza virus nucleoprotein 
was carried out for the detection of apoptosis. Furthermore, primary culture of human alveolar 
epithelial cells was isolated from human lungs by mincing the lung, followed by filtration and 
centrifugation. Human alveolar epithelial cells were infected with the novel influenza H7N9, the HPAI 
H5N1, and the pandemic H1N1 virus. Virus replication was monitored by measuring infectious viral 
particles using TCID50. mRNA and protein expression of proinflammatory cytokines and chemokines 
were quantified by real time qPCR and ELISA. Results: We found extensive apoptosis in influenza 
H7N9 (both SH1 and SH2) and H5N1, but not H1N1pdm infected ex vivo lung tissues, suggesting that 
both avian influenza viruses can induce apoptosis and cause severe cell death in human lung tissue. 
Furthermore, unlike HPAI H5N1 which induces dysregulated proinflammatory cytokine responses, the 
novel influenza H7N9 virus elicited poor proinflammatory cytokine responses, inducing type I and III 
interferon in ex vivo human lung explant cultures. The novel influenza H7N9 virus is an intrinsically 
more potent inducer of proinflammatory cytokine than the H1N1pdm virus but less than the H5N1 
virus. Conclusions: The proinflammatory cytokine and chemokine responses may contribute modestly 
to the severity of human H7N9 disease, but it is likely that direct viral cytopathology is probably 
playing a more important role in pathogenesis of human H7N9 diseases. The recognition of the role of 
cleaved caspase 3 in severe human infection of avian influenza virus can provide insights on the 
development of novel therapeutic approaches for the preparedness of the future outbreak of 
pandemics. 
P1-107 
Antigenic and genetic evolution of low pathogenic avian influenza viruses 
(H7N3) following heterologous vaccination 
MS Beato1*, Y Xu2, LP Long2, I Capua1, XF Wan2 
1OIE/FAO and National Reference Laboratory for Avian Influenza and Newcastle Disease, OIE 
Collaborating Centre for Infectious Diseases at the Human-Animal Interface, Istituto Zooprofilattico 
Sperimentale delle Venezie (IZSVe), Viale dell’Università, Legnaro (PD), Italy; 2Department of Basic 
Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi 
Background: Italy experienced H7N3 low pathogenic avian influenza (LPAI) outbreaks between 2002 
and 2004 in a densely populated poultry area in the northeast. The H7N3 virus was first detected in 
October 2002 in poultry. This virus continued to circulate and the infection was controlled by August 
2003 by stamping out, control of movements, improved bio-security, and heterologous vaccination. A 
vaccination program was designed based on a “DIVA” strategy and was carried out using an AI 
inactivated heterologous H7N1 vaccine and implemented from December 2002 to August 2003. In 
2003, the virus circulated in unvaccinated and vaccinated poultry farms. In September 2004, 
approximately 1 year after the depopulation of the last LPAI affected flock, the AI virus of the H7N3 
subtype re-emerged. This occurrence required the application of strict control measures in association 
with the rapid implementation of a booster immunization of the susceptible population. During the 
2002-2004 Italian LPAI H7N3 epidemic, a longitudinal collection of H7N3 viruses was obtained and 
archived. To shed light on the occurrence, temporal pattern and genetic basis of antigenic drift for 
avian influenza (AI) viruses in absence and presence of heterologous vaccination, these viruses were 
subjected to genetic and antigenic characterization. Materials and Methods: H7N3 AI isolates were 
selected in this study according to the following criteria: 1) year of isolation; 2) vaccination status of 
the flock from which they were isolated. A total of 37 H7N3 isolates were selected. In particular, 16 
H7N3 isolates were isolated during the 2002 epidemic (no vaccination campaign in place); 11 isolates 
collected in 2003 from unvaccinated (4 viruses) and vaccinated flocks (7 viruses); and 10 H7N3 
isolates sampled from vaccinated farms during the 2004 epidemic were analysed, the latter were all 
available viruses isolated in 2004. Turkey sera were generated against representative H7N3 isolated 
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